Key result
Apparent treatment-resistant hypertension linked to increased cardiovascular disease risk, modified by sex and age.
Why the study?
A limited number of studies have tested the magnitude of the association between apparent treatment resistant hypertension and risk of CVD.
Is apparent treatment resistant hypertension associated with an increased risk of cardiovascular disease in older adults with hypertension?
Observational (n=25,516)
Yes
Is apparent treatment resistant hypertension associated with an increased risk of cardiovascular disease in older adults with hypertension?
Apparent treatment resistant hypertension is associated with an increased risk of cardiovascular events, with the risk magnitude modified by patient sex and age.
BACKGROUND: A limited number of studies have been conducted to test the magnitudes of the association between apparent treatment resistant hypertension (aTRH) and risk of cardiovascular disease (CVD). AIM: To investigate the association between aTRH and risk of CVD and examine whether sex and age modify this association. METHODS: = 25516) from 625 primary care settings throughout the United States, Canada, Puerto Rico, and United States Virgin Islands, aged 55 and older with hypertension and at least one additional risk factor for heart disease. aTRH was assessed from the year 2 visit. CVD event was defined as one of the following from the year 2 follow-up visit: Fatal or non-fatal myocardial infarction, coronary revascularization, angina, stroke, heart failure, or peripheral artery disease. Cox proportional hazards regression was used to examine the effect of aTRH on CVD risk. Potential modifications of sex and age on this association were examined on the multiplicative scale by interaction term and additive scale by joint effects and relative excess risk for interaction. CONCLUSION: aTRH was significantly associated with an increased risk of CVD and this association was modified by both sex and age. Further studies are warranted to test these mechanisms.
No takes yet. Share an insight, caveat, or question.
Nelson et al. (2023) conducted an observational in Hypertension (n=25,516). Apparent treatment resistant hypertension (aTRH) was evaluated on Fatal or non-fatal myocardial infarction, coronary revascularization, angina, stroke, heart failure, or peripheral artery disease (p=>0.05). In a cohort of 25,516 patients, apparent treatment resistant hypertension was significantly associated with an increased risk of cardiovascular disease, with effects modified by sex and age.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: